How Do Coronary Lipid-Rich Plaques Change After Cessation of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors? ― Serial Assessment Using Near-Infrared Spectroscopy ―
Open Access
- 21 July 2021
- journal article
- editorial
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 85 (8), 1404-+
- https://doi.org/10.1253/circj.cj-21-0211
Abstract
Access full-text academic articles: J-STAGE is an online platform for Japanese academic journals.Keywords
This publication has 2 references indexed in Scilit:
- Clinical impact of PCSK9 inhibitor on stabilization and regression of lipid-rich coronary plaques: a near-infrared spectroscopy studyEuropean Heart Journal – Cardiovascular Imaging, 2021
- Effect of PCSK-9 Inhibitors on Lipid-Rich Vulnerable Coronary Plaque Assessed by Near-Infrared SpectroscopyJACC: Cardiovascular Imaging, 2020